Literature DB >> 20979442

Bioresponsive hyperbranched polymers for siRNA and miRNA delivery.

Ulrik L Rahbek1, Anne F Nielsen, Mingdong Dong, Yezi You, Anne Chauchereau, David Oupicky, Flemming Besenbacher, Jørgen Kjems, Kenneth A Howard.   

Abstract

This work presents the novel use of reducible hyperbranched (rHB) polymers for delivery of RNA interference (RNAi) therapeutics. Cationic poly(amido amine) hyperbranched polymers that contain different contents of reducible disulfide to nonreducible linkages (0%, 17%, 25%, and 50%) were used to form interpolyelectrolyte polyplexes with siRNA and precursor miRNA (pre-miRNA). Atomic force microscopy (AFM) revealed rHB complexes of ∼100 nm in size, which exhibited redox-activated disassembly in the presence of dithiothreitol (DTT). The complexes were avidly internalized and showed no cellular toxicity in an endogenous enhanced green fluorescence protein (EGFP) expressing H1299 human lung cancer cell line. The highest specific EGFP gene silencing (∼75%) was achieved with rHB (17%)/siRNA complexes at a weight-to-weight (w/w) ratio of 40 that correlated with the ability for this polymer to successfully transfect pre-miRNA. Evaluation of temporal silencing levels over 72 h revealed incremental knockdown that reached a maximum at 72 h for the rHB (50%) complexes, in contrast to maximum knockdown at 24 h that remained relatively consistent, thereafter, for the rHB (17%), rHB (25%), and non-rHB complexes. The role of particle disassembly for intracellular targeting and modulation of gene silencing addressed in this work are important considerations in the development of this and other next-generation delivery systems.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20979442     DOI: 10.3109/1061186X.2010.527982

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  8 in total

Review 1.  All's well that transcribes well: non-coding RNAs and post-stroke brain damage.

Authors:  Raghu Vemuganti
Journal:  Neurochem Int       Date:  2013-08-15       Impact factor: 3.921

2.  The application of RNAi-based treatments for inflammatory bowel disease.

Authors:  Morten Tobias Jarlstad Olesen; Borja Ballarín-González; Kenneth Alan Howard
Journal:  Drug Deliv Transl Res       Date:  2014-02       Impact factor: 4.617

3.  Reducible Branched Ester-Amine Quadpolymers (rBEAQs) Codelivering Plasmid DNA and RNA Oligonucleotides Enable CRISPR/Cas9 Genome Editing.

Authors:  Yuan Rui; David R Wilson; Katie Sanders; Jordan J Green
Journal:  ACS Appl Mater Interfaces       Date:  2019-03-08       Impact factor: 9.229

Review 4.  Design of polymeric nanoparticles for biomedical delivery applications.

Authors:  Mahmoud Elsabahy; Karen L Wooley
Journal:  Chem Soc Rev       Date:  2012-02-14       Impact factor: 54.564

Review 5.  Getting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-Review.

Authors:  Ming Ming Wen
Journal:  Front Mol Neurosci       Date:  2016-11-22       Impact factor: 5.639

6.  Synthesis and characterization of hyperbranched poly(ester-amine) by Michael addition polymerization.

Authors:  Miao Sun; Chunxiao Yin; Yanan Gu; Yun Li; Zhirong Xin
Journal:  Des Monomers Polym       Date:  2017-07-13       Impact factor: 2.650

7.  Circulating exosomal microRNA-96 promotes cell proliferation, migration and drug resistance by targeting LMO7.

Authors:  Hao Wu; Jingcheng Zhou; Shanshan Mei; Da Wu; Zhimin Mu; Baokun Chen; Yuancai Xie; Yiwang Ye; Jixian Liu
Journal:  J Cell Mol Med       Date:  2016-12-27       Impact factor: 5.310

8.  Delivery of mRNA to platelets using lipid nanoparticles.

Authors:  S Novakowski; K Jiang; G Prakash; C Kastrup
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.